Table 2 Total macroeconomic burden, economic burden as a percentage of total GDP in 2020–2050 and per capita economic burden attributable to diabetes mellitus mortality and morbidity by World Bank region and by World Bank income group in 2017 INT$
Region/income group | Economic burden in billions of 2017 INT$ | Percentage of total GDP in 2020–2050 | Per capita loss in 2017 INT$ |
|---|---|---|---|
By region | |||
East Asia and Pacific | 3,104 (2,336–4,115) | 0.190 (0.143–0.252) | 1,261 (949–1,672) |
Europe and Central Asia | 2,018 (1,549–2,633) | 0.211 (0.162–0.275) | 2,168 (1,665–2,829) |
Latin America and Caribbean | 629 (467–837) | 0.229 (0.170–0.305) | 876 (651–1,166) |
Middle East and North Africa | 487 (364–654) | 0.192 (0.144–0.258) | 866 (647–1,163) |
North America | 2,595 (2,217–3,049) | 0.385 (0.329–0.453) | 6,497 (5,551–7,635) |
South Asia | 1,218 (840–1,711) | 0.197 (0.136–0.276) | 577 (398–811) |
Sub-Saharan Africa | 163 (109–239) | 0.097 (0.065–0.142) | 99 (67–146) |
By income group | |||
Low income | 65 (42–97) | 0.101 (0.066–0.152) | 67 (44–101) |
Lower-middle income | 2,296 (1,571–3,251) | 0.206 (0.141–0.292) | 583 (399–826) |
Upper-middle income | 2,673 (2,047–3,490) | 0.166 (0.127–0.217) | 1,009 (772–1,317) |
High income | 5,152 (4,206–6,360) | 0.289 (0.236–0.357) | 4,159 (3,395–5,133) |
Total | 10,216 (7,884–13,241) | 0.223 (0.172–0.289) | 1,157 (893–1,499) |
